NCT06403046View on ClinicalTrials.gov

Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 7, 2025

Study Completion Date

September 7, 2025

Conditions
Temporomandibular Joint Disc Displacement, With Reduction
Interventions
DRUG

intraarticular injection

all patients will be subjected to routine (TMJ) arthrocentesis followed by Tenoxicam injection into the superior joint space in the (Tx group) and Meloxicam injection among the patients of (Mx group).

Trial Locations (1)

Unknown

Beni-suef university, Banī Suwayf

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT06403046 - Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement | Biotech Hunter | Biotech Hunter